financetom
Business
financetom
/
Business
/
US regulator denies Shell's request for older Venture Global LNG's documents
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US regulator denies Shell's request for older Venture Global LNG's documents
Oct 10, 2024 2:21 PM

HOUSTON (Reuters) - Shell on Thursday lost a bid to have U.S. regulators allow it to view nonpublic commissioning documents related to Venture Global LNG's Calcasieu Pass facility, a setback in a broader dispute over access to cargoes from the plant.

Shell, BP, Galp, Repsol, Orlen ( PSKOF ) and Edison have launched contract arbitration cases in the U.S. and Europe with over the status of the plant and their inability to obtain contract cargoes for more than two years.

Shell and others say they have lost billions of dollars in profit from gas promised under long-term contracts but was not delivered. Venture Global LNG contends it has not fully commissioned the Louisiana plant.

The buyers have challenged that contention by initiating arbitration and regulatory proceedings and in their regulatory battle have won access to some confidential commissioning documents filed with the U.S. Federal Energy Regulatory Commission.

FERC's ruling on Thursday allows the parties to see nonpublic documents from Jan. 1, 2022, before the plant started operations. But the administrative law judge appointed by FERC rejected the request for all nonpublic documents, including those that precede the January 2022 deadline, to be turned over to Shell.

Judge Matthew J. Vlissides Jr. ruled that Venture Global LNG is not required to serve nonpublic documents filed with the Commission other than those from Jan. 1, 2022.

Neither Venture Global nor Shell was immediately available for comment.

The judge also noted that Shell was the only company that requested documents dated before January 2022.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla Stock Suffers Worst Day In 5 Years After 7 Consecutive Weeks Of Declines (UPDATED)
Tesla Stock Suffers Worst Day In 5 Years After 7 Consecutive Weeks Of Declines (UPDATED)
Mar 10, 2025
Editor's Note: This article has been updated to include historical price action. Tesla, Inc. ( TSLA ) shares are plunging Monday. The stock has been under pressure amid rising competition from Chinese electric vehicle (EV) manufacturers, declining demand in Europe and protests at Tesla facilities. What To Know: Tesla shares are coming off their seventh straight week of declines, marking...
Exclusive-Bank of America eliminates some investment banking roles, including in New York
Exclusive-Bank of America eliminates some investment banking roles, including in New York
Mar 10, 2025
NEW YORK (Reuters) - Bank of America ( BAC ) eliminated some investment banking roles on Monday, including in New York, according to three sources familiar with the situation who declined to be identified discussing personnel matters. The cuts affected junior bankers, including analysts and associates, the three sources said. The employees could be redeployed in comparable positions elsewhere in...
CBS urges FCC to reject complaint over '60 Minutes' Harris interview
CBS urges FCC to reject complaint over '60 Minutes' Harris interview
Mar 10, 2025
March 10 (Reuters) - CBS on Monday urged the Federal Communications Commission to reject a complaint over a 60 Minutes interview with then-Vice President Kamala Harris, saying the agency has no lawful role in policing broadcast news editorial decisions. CBS, which is owned by Paramount Global ( PARAA ), said sanctioning the company over the interview would blatantly violate the...
US FDA to hold off action on weight-loss drug copies pending court ruling
US FDA to hold off action on weight-loss drug copies pending court ruling
Mar 10, 2025
March 10 (Reuters) - The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk's weight-loss drug Wegovy until a federal court delivers its ruling in a lawsuit against the agency. The health regulator announced last month that there was no longer a shortage of Novo's Wegovy and diabetes...
Copyright 2023-2026 - www.financetom.com All Rights Reserved